Spai Health (00314) acquired a total of 7.28 million shares of the company from executive directors Ma Xuguang and Li Jizeng

Zhitong Finance App News, Sipai Health (00314) issued an announcement. The board of directors of the company was informed by executive directors Ma Xuguang and Mr. Li Ji. Based on firm confidence in the company's future development prospects and recognition of its long-term investment value, on July 15, 2026, Mr. Ma Xuguang acquired 3.64 million shares of the company through Lucky Seven Healthcare Co., Ltd. and Mr. Li Ji through Spire-Succession Limited, respectively, at a price of HK$1.40 per share Common shares (a total of 7.28 million shares of the company, accounting for approximately 1.00% of the total number of shares issued as of the date of this announcement (excluding treasury shares)).

Following the increase in holdings and as of the date of this announcement, Mr. Ma Xuguang held 60.64 million shares, accounting for approximately 8.34% of the total number of issued shares (excluding treasury shares). Mr. Li Ji holds 43.64 million shares, accounting for about 6.00% of the total number of issued shares (excluding treasury shares).

From January 1, 2026 to the date of this announcement, the company bought back a total of 22.4 million shares, with a total consideration of approximately HK$446.94 million, further demonstrating the company's confidence in its long-term development and value.